Our mission is to conduct effective advocacy for public policies that encourage the discovery of important, new medicines for patients by biopharmaceutical research companies. To accomplish this mission, we are dedicated to achieving these goals in Washington, D.C. and across the country.

Featured Blogs

The White House continues to attack American innovation

Stephen J. Ubl
The Biden Administration is sending a very clear message to American innovators: “We no longer have your back.”

New analysis shows PBMs use fees as a profit center

Stephen J. Ubl
Pharmacy benefit managers (PBMs) demand more than double the amount of fees today than they did five years ago, according to a new report from Nephron Research.

How the 340B program became a PBM giveaway

Nicole Longo
Congress should be asking themselves: How did a program meant for safety-net hospitals and clinics become a PBM giveaway?

This website uses cookies and other tracking technologies to optimize performance, preferences, usage, and statistics. By clicking “Accept All”, you consent to store on your device the cookies and other tracking technologies that require consent. You can tailor or change your preferences by clicking “Manage My Cookies”. You can check our privacy policy for more information.